The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Discovery of Inhibitors that Elucidate the Role of UCH-L1 Activity in the H1299 Lung Cancer Cell Line
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal Hydrolase
Wilkinson, K. D., Lee, K., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., & Pohl, J. (1989) · Science · doi:10.1126/science.2530630 · Cited by 871
Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., & Lansbury, P. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01012-7 · Cited by 785
Self-citationRegulation of ubiquitin‐dependent processes by deubiquitinating enzymes
Wilkinson, K. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.14.9409543 · Cited by 577
Grozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
Saigoh, K., Wang, Y.-L., Suh, J.-G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T., et al. (1999) · Nature Genetics · doi:10.1038/12647 · Cited by 502
Substrate Specificity of Deubiquitinating Enzymes: Ubiquitin C-Terminal Hydrolases
Larsen, C. N., Krantz, B. A., & Wilkinson, K. D. (1998) · Biochemistry · doi:10.1021/bi972274d · Cited by 391
Structural basis for the specificity of ubiquitin C-terminal hydrolases
Johnston, S. C., Riddle, S. M., Cohen, R. E., & Hill, C. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3877 · Cited by 288
Haggarty, S. J., Mayer, T. U., Miyamoto, D. T., Fathi, R., King, R. W., Mitchison, T. J., & Schreiber, S. L. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00101-0 · Cited by 251
Dang, L. C., Melandri, F. D., & Stein, R. L. (1998) · Biochemistry · doi:10.1021/bi9723360 · Cited by 232
Self-citationLarsen, C. N., Price, J. S., & Wilkinson, K. D. (1996) · Biochemistry · doi:10.1021/bi960099f · Cited by 215
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson’s disease
Maraganore, D. M., Farrer, M. J., Hardy, J. A., Lincoln, S. J., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.53.8.1858 · Cited by 209
Momose, Y., Murata, M., Kobayashi, K., Tachikawa, M., Nakabayashi, Y., Kanazawa, I., & Toda, T. (2002) · Annals of Neurology · doi:10.1002/ana.10079 · Cited by 198
Deubiquitinating Enzymes: Their Diversity and Emerging Roles
Chung, C. H., & Baek, S. H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1880 · Cited by 175
PGP9.5 As a Candidate Tumor Marker for Non-Small-Cell Lung Cancer
Hibi, K., Westra, W. H., Borges, M., Goodman, S., Sidransky, D., & Jen, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65169-3 · Cited by 171
PGP9.5 as a prognostic factor in pancreatic cancer.
Tezel, E., Hibi, K., Nagasaka, T., & Nakao, A. (2000) · PubMed · Cited by 139
PGP9.5 as a marker for invasive colorectal cancer.
Yamazaki, T., Hibi, K., Takase, T., Tezel, E., Nakayama, H., Kasai, Y., Ito, K., Akiyama, S., Nagasaka, T., & Nakao, A. (2002) · PubMed · Cited by 139
Interaction and colocalization of PGP9.5 with JAB1 and p27Kip1
Caballero, O. L., Resto, V. A., Patturajan, M., Meerzaman, D. M., Guo, M. Z., Engles, J. M., Yochem, R. L., Ratovitski, E. A., Sidransky, D., & Jen, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205390 · Cited by 111
Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia
Kurihara, L. J., Kikuchi, T., Wada, K., & Tilghman, S. M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.18.1963 · Cited by 108
Elbaz, A., Lévecque, C., Clavel, J., Vidal, J., Richard, F., Corrèze, J., Delemotte, B., Amouyel, P., Alpérovitch, A., Chartier‐Harlin, M., et al. (2002) · Movement Disorders · doi:10.1002/mds.10326 · Cited by 76
A Role of the Ubiquitin–Proteasome System in Neuropathic Pain
Moss, A., Blackburn-Munro, G., Garry, E. M., Blakemore, J., Dickinson, T., Rosie, R., Mitchell, R., & Fleetwood-Walker, S. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01363.2002 · Cited by 64
Neuropathology of gracile axonal dystrophy (GAD) mouse
Mukoyama, M., Yamazaki, K., Kikuchi, T., & Tomita, T. (1989) · Acta Neuropathologica · doi:10.1007/bf00294664 · Cited by 63
Sasaki, H. (2001) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hye113 · Cited by 53
ACT and UCH‐L1 polymorphisms in Parkinson's disease and age of onset
Wang, J., Zhao, C., Si, Y.-M., Liu, Z., Chen, B., & Yu, L. (2002) · Movement Disorders · doi:10.1002/mds.10179 · Cited by 52
Miura, H., Oda, K., Endo, C., Yamazaki, K., Shibasaki, H., & Kikuchi, T. (1993) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1993.tb00403.x · Cited by 44
Lévecque, C., Destée, A., Mouroux, V., et al. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170017 · Cited by 44
Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues
Rosas, S. L. B., Caballero, O. L., Dong, S. M., Carvalho, M. D. G., Sidransky, D., & Jen, J. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00449-9 · Cited by 41
Oda, K., Yamazaki, K., Miura, H., Shibasaki, H., & Kikuchi, T. (1992) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1992.tb00789.x · Cited by 36
Satoh, J., & Kuroda, Y. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00313.x · Cited by 33
Sunday, M. E., Willett, C. G., Graham, S. A., Oreffo, V. I. C., Linnoila, R. I., & Witschi, H. R. (1995) · PubMed · Cited by 31
Kinetic Studies on the Inhibition of Isopeptidase T by Ubiquitin Aldehyde
Melandri, F. D., Grenier, L., Plamondon, L., Huskey, W. P., & Stein, R. L. (1996) · Biochemistry · doi:10.1021/bi9612935 · Cited by 31
Self-citationMaki, A., Mohammad, R. M., Smith, M. R., & Al-Katib, A. M. (1996) · Differentiation · doi:10.1046/j.1432-0436.1996.6010059.x · Cited by 17
Cited by
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082307.091526 · Cited by 1,396
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Emerging principles in protease-based drug discovery
Drag, M., & Salvesen, G. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3053 · Cited by 601
Metadata
- Authors
- Liu, Y., Lashuel, H. A., Choi, S., Xing, X., Case, A., Ni, J., Yeh, L.-A., Cuny, G. D., Stein, R. L., & Lansbury, P. T.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 10
- Issue
- 9
- Pages
- 837-846
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W2068931555
- Cited by
- 256
- References
- 34
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.